Summary of German‐Austrian HIV PrEP guideline-Reference-Cited by-同舟云学术

Summary of German‐Austrian HIV PrEP guideline

Published:2019-05-29 Issue: Volume: Page:
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Spinner CD¹^ORCID,Lang GF²,Boesecke C³,Jessen H⁴,Schewe K⁵,Stellbrink Hans‐Jürgen,Esser Stefan,Haberl Annette,Römer Katja,Plettenberg Andreas,Rockstroh Jürgen,Scholten Stefan,Weber Christoph,Haas Bernhard,Lehmann Clara,de Leuw Philipp,Brockmeyer Norbert,Schmiedel Stefan,Kaiser Rolf,Kaiser Rolf,Marcus Ulrich,Schafberger Armin,Schwarze Siegfried,Feustel Nicholas,Langanke Harriet,Claass Johanna,

Affiliation:

1. Department of Medicine II University Hospital Klinikum rechts der Isar Technische Universität München Munich Germany

2. Division of Allergy, Immunology and Infectious Diseases Department of Dermatology Medical University of Vienna Vienna Austria

3. Department of Medicine I University Hospital Bonn Bonn Germany

4. Praxis Jessen² + Kollegen, Private Practice Berlin Germany

5. ICH Hamburg, Private Practice Hamburg Germany

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.12724

Reference20 articles.

1. Emtricitabine‐tenofovir concentrations and pre‐exposure prophylaxis efficacy in men who have sex with men;Anderson PL;Sci Transl Med,2012

2. WHO.Consolidated guidelines on HIV prevention diagnosis treatment and care for key populations [Internet]. Available athttp://www.who.int/hiv/pub/guidelines/keypopulations/en/(accessed 26 March 2015).

3. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial;Sagaon‐Teyssier L;AIDS Care,2016

4. Pre‐exposure prophylaxis to prevent the acquisition of HIV‐1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open‐label randomised trial;McCormack S;Lancet,2016

5. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double‐blind, placebo‐controlled phase 3 trial;Choopanya K;Lancet,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic;Frontiers in Pharmacology;2023-11-03

2. Evaluation of Self-Collected Versus Health Care Professional (HCP)-Performed Sampling and the Potential Impact on the Diagnostic Results of Asymptomatic Sexually Transmitted Infections (STIs) in High-Risk Individuals;Infectious Disease Reports;2023-08-25

3. Seroconversion rate of SARS-CoV-2 IgG antibodies and dating behaviour in HIV-PrEP users in a German metropolis during the COVID-19 pandemic;International Journal of STD & AIDS;2023-07-17

4. High Prevalence of Asymptomatic Sexually Transmitted Infections in Austrian Pre-Exposure Prophylaxis Users: A Prospective Observational Study;AIDS Patient Care and STDs;2023-03-01

5. Impact of COVID-19 Confinement on Mental Health in Youth and Vulnerable Populations: An Extensive Narrative Review;Sustainability;2023-02-08